4.2 Article

Mechanisms of isolevuglandin-protein adduct formation in inflammation and hypertension

Journal

PROSTAGLANDINS & OTHER LIPID MEDIATORS
Volume 139, Issue -, Pages 48-53

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.prostaglandins.2018.09.008

Keywords

Hypertension; Inflammation; Isolevuglandins

Funding

  1. National Institutes of Health [K01HL130497]
  2. American Heart Association Scientist Development Grant [17SDG33670829]
  3. National Center for Advancing Translational Sciences [UL1 TR002243]

Ask authors/readers for more resources

Inflammation has been implicated in the pathogenesis of hypertension and recent evidence suggests that isolevuglandin (IsoLG)-protein adducts play a role. Several hypertensive stimuli contribute to formation of IsoLG-protein adducts including excess dietary salt and catecholamines. The precise intracellular mechanisms by which these hypertensive stimuli lead to IsoLG-protein adduct formation are still not well understood; however, there is now evidence implicating NADPH-oxidase derived reactive oxygen species (ROS) in this process. ROS oxidize arachidonic acid leading to formation of IsoLGs, which non-covalently adduct to lysine residues and alter protein structure and function. Recent studies suggest that these altered proteins act as neo-antigens leading to an autoimmune state that results in hypertension. The goal of this mini-review is to highlight some of the hypertensive stimuli and the mechanisms contributing to IsoLG-protein adduct formation leading to inflammation and hypertension.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available